SOL MAYER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Enveric Biosciences, Inc.

Filing Date Source Excerpt
2021-04-13 Sol Mayer
2022-05-31 Name Fees earned or paid in cash ($) Equity awards ($) Total ($) Sol Mayer 34,250 76,594 110,844 Consists of RSA’s equivalent to 15,957 shares of Common Stock, valued at $4.80 per share (the closing price per share on the date of the award). As of December 31, 2021, Sol Mayer had outstanding 15,957 RSA’s.

Data sourced from SEC filings. Last updated: 2026-02-03